key: cord-1012875-7i5o9jso
authors: Shlomai, Amir; Ben-Zvi, Haim; Glusman Bendersky, Ahinoam; Shafran, Noa; Goldberg, Elad; Sklan, Ella H.
title: Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients
date: 2020-09-01
journal: Crit Care
DOI: 10.1186/s13054-020-03244-3
sha: 959ab6e78ccd2c89dec7e973f892d5dec0aa676c
doc_id: 1012875
cord_uid: 7i5o9jso

nan

The SARS-CoV-2 pandemic imposes an unprecedented burden on hospitals treating coronavirus disease 2019 (COVID-19) patients. Thus, clinical parameters accurately predicting disease outcome are needed. Here, we identified a correlation between viral load measured around admission, lung inflammation, and disease outcome. Similarities and differences between related studies are discussed.

Viral loads of COVID-19 patients admitted to Rabin Medical Center between March 16 and July 23, 2020, were analyzed (n = 170, females 42%, age 62 (IQR 46-73), hospitalization length 7.5 days (IQR 3-13)). Clinical and demographic data were collected from the patients' electronic medical records. Nasopharyngeal samples were collected and transferred to the microbiology laboratory for testing. Quantitative RT-PCR was performed using the Allplex™ 2019-nCoV Assay (Seegene). Presented are Ct values of the nucleocapsid N gene from the first test performed for each patient. Simple linear regression of clinical parameters against the viral load was fitted to the data to assess the association between viral and clinical parameters using GraphPad Prism. Adjusted odds ratio (OR) of mechanical ventilation and mortality were calculated for each significant variable with 95% confidence intervals (CI) using SPSS, version 26.

Cycle threshold values of the first test performed for all admitted COVID-19 patients were correlated with the patients' clinical parameters. Among the parameters tested (lowest values of albumin, lymphocyte count, blood oxygen saturation (BOS) and systolic blood pressure, peak levels of lactate dehydrogenase (LDH), Creactive protein (CRP), ferritin, white blood cell count, and fever), only BOS min (R = 0.07, p = 0.0004) showed significant correlation (Fig. 1) . Interestingly, patients' age was also significantly correlated with viral load (Fig. 1 ). Non-survivors and mechanically ventilated patients (n = 21) had a significantly higher viral load (8-folds, Ct = 23.43 ± 5.38) compared to surviving non-intubated patients (n = 149, Ct = 29 ± 5.55, t test p < 0.0001, Fig. 2) . A multivariate analysis adjusted for age, gender, and BOS min revealed that low viral load was independently associated with reduced risk for mechanical ventilation and mortality (OR = 0.90, 95% CI 0.81-0.99, p = 0.046). Furthermore, BOS and patients' age were also independently associated with mechanical ventilation and death (OR = 0.91, 95% CI 0.84-0.98, p = 0.009 for BOS and OR = 1.05, 95% CI 1.004-1.097 for age).

Our results show a direct link between nasopharyngeal viral load and hypoxemia, as well as worse disease outcomes in admitted patients with COVID-19. Previous studies tested the association between viral load and survival. In agreement with our results, a study of 678 admitted patients in New York found that 35.0% of patients with a high viral load on admission died, compared to 6.2% of patients with low viral loads [1] . In an older age cohort (n = 48, age 67-97) from Belgium, clinical frailty scale, LDH, and viral load predicted survival [2] . Intensive care unit (ICU) admission also positively correlated with detectable viral RNA in anal swabs [3] . In contrast, a Swiss study found no correlation between viral load and disease outcome. The study compared the viral load of patients admitted to the ICU (n = 48) to patients treated in a screening unit (n = 723) [4] . It is not clear, however, whether these patients were later admitted, intubated, or survived. A different New York study (n = 205) found no association between viral load and disease severity parameters. However, this study mainly compared non-hospitalized to hospitalized patients [5] . Several markers were associated with COVID-19 severity, the most accepted is IL-6 [6] . However, IL-6 is not routinely tested at admission and might reflect other inflammatory conditions. Thus, in spite of differences in test kits and procedures between different laboratories and institutions, viral load might provide a rapid screening tool for COVD-19 severity among admitted patients. 

Impact of SARS-CoV-2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019

Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study

Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019

Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses. medRxiv

Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms

The role of interleukin-6 in monitoring severe case of coronavirus disease 2019

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Acknowledgements EHS acknowledges the Milner Foundation for its support.Authors' contributions AS, EHS, and EG designed the work. AS, EHS, HBZ, AGB, and NS collected and analyzed the data. AS and EHS interpreted the data. EHS and AS drafted the work. All authors read and approved the final manuscript.

No funding to declare.

The dataset supporting the conclusions of this article is available from the authors upon request.

This retrospective study was approved by the Rabin Medical Center Helsinki Committee (0252-20-RMC) and the Tel Aviv University Ethics Committee (0001269-3). The need for informed consent was waived due to its retrospective nature.

Not applicable.Competing interests Not applicable.